- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06634732
Quantitative Ultrasound Assessment of Abdominal Cavity Space
October 8, 2024 updated by: Ruijin Hospital
Study on the Application Value of Quantitative Ultrasound Assessment Plan for Abdominal Cavity Space in Critically Ill Patients
This is a prospective observational study to observe the diagnostic efficacy of a quantitative ultrasound assessment plan for pathological accumulation in the abdominal cavity space of critically ill patients, and to explore its correlation with patient clinical outcomes.
Study Overview
Detailed Description
Intra-abdominal lesions, such as hemorrhage and inflammation/infection, often lead to pathological accumulations, posing serious challenges for critically ill patients.
These lesions can rapidly induce intra-abdominal hypertension and organ damage, which may progress to hemorrhagic or septic shock, endangering patients' lives.
Intra-abdominal hemorrhage, especially surgery-related hemorrhage, is difficult to detect early, and existing assessment methods like CT scans have limited applicability in critically ill patients.
Intra-abdominal infections account for a high proportion of infections in critically ill patients, with concurrent sepsis or shock having high mortality rates.
Despite advancements in critical care medicine, the mortality rate from intra-abdominal infections remains stubbornly high.
Accurate assessment of the source and extent of infection is crucial for treatment, yet routine physical examinations have low sensitivity in critically ill patients, making imaging examinations the primary method.
However, while abdominal CT is considered the gold standard, it is limited by insufficient dynamic monitoring and difficulties in patient transport.
Bedside ultrasound plays a significant role in the monitoring of critically ill patients due to its portability, non-invasiveness, and real-time dynamic capabilities.
It can assess sources of hemorrhage and infection, quantify the extent of lesions, and monitor hemodynamic changes.
Therefore, this study aims to develop a comprehensive ultrasound assessment protocol that covers the peritoneal cavity and posterior peritoneal space.
Through a prospective observational study, we aim to validate its sensitivity and specificity in diagnosing pathological accumulations such as intra-abdominal hemorrhage/infection and explore its correlation with patient clinical outcomes.
Study Type
Observational
Enrollment (Estimated)
125
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Weiqing Zhang, Ph.D
- Phone Number: 8618521525300
- Email: weiq.zh@163.com
Study Locations
-
-
Shanghai
-
Shanghai, Shanghai, China, 200025
- Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Critically ill patients in the Department of Critical Care Medicine at Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University
Description
Inclusion Criteria:
- Age > 18 years old;
- Expected ICU stay ≥ 72 hours;
- Meeting one of the diagnostic criteria for intra-abdominal infection: 1) Single organ infection (such as cholecystitis, appendicitis, diverticulitis, cholangitis, pancreatitis, salpingitis, etc.), which may be accompanied by or without peritonitis, even without perforation; 2) Peritonitis, classified as primary, secondary, or recurrent; 3) Intra-abdominal abscess.
Exclusion Criteria:
- Patients with wounds, redness, swelling, bleeding, or other conditions at the abdominal measurement points that prevent ultrasound assessment;
- Patients with intra-abdominal gas accumulation that affects abdominal ultrasound imaging, making ultrasound quantitative scoring impossible;
- Patients who have not undergone abdominal CT examination within 72 hours of ICU admission;
- Patients who do not consent to participate in this study.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
observational group
Subjectives will undergo abdominal ultrasound examination immediately after receiving an abdominal CT scan.after
admission to the ICU.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Quantitative CT Scoring for Pathological Accumulations in the Abdominal Cavity Space
Time Frame: up to 3 days after admission to ICU
|
score range from 0-20, higher scores indicate a worse outcome
|
up to 3 days after admission to ICU
|
|
Quantitative Ultrasound Scoring for Pathological Accumulations in the Abdominal Cavity Space
Time Frame: up to 3 days after admission to ICU
|
score range from 0-20, higher scores indicate a worse outcome
|
up to 3 days after admission to ICU
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Time to initiate enteral nutrition
Time Frame: up to 3 days after admission to ICU
|
Time to initiate enteral nutrition after admission to ICU in hours
|
up to 3 days after admission to ICU
|
|
Intra-abdominal pressure
Time Frame: up to 3 days after admission to ICU
|
Intra-abdominal pressure in mmHg
|
up to 3 days after admission to ICU
|
|
C-reactive protein
Time Frame: up to 3 days after admission to ICU
|
C-reactive protein in mg/L
|
up to 3 days after admission to ICU
|
|
procalcitonin
Time Frame: up to 3 days after admission to ICU
|
procalcitonin in ng/L
|
up to 3 days after admission to ICU
|
|
white blood cell count
Time Frame: up to 3 days after admission to ICU
|
white blood cell count
|
up to 3 days after admission to ICU
|
|
time to achieve enteral nutrition targets
Time Frame: up to 28 days after admission to ICU
|
time to achieve enteral nutrition targets in hours
|
up to 28 days after admission to ICU
|
|
serum albumin
Time Frame: up to 28 days after admission to ICU
|
serum albumin in g/L
|
up to 28 days after admission to ICU
|
|
prealbumin
Time Frame: up to 28 days after admission to ICU
|
prealbumin in mg/L
|
up to 28 days after admission to ICU
|
|
Duration of Continuous Renal Replacement Therapy treatment
Time Frame: up to 28 days after admission to ICU
|
Duration of CRRT (Continuous Renal Replacement Therapy) treatment in hours
|
up to 28 days after admission to ICU
|
|
duration of mechanical ventilation
Time Frame: up to 28 days after admission to ICU
|
duration of mechanical ventilation in hours
|
up to 28 days after admission to ICU
|
|
length of ICU stay
Time Frame: up to 28 days after admission to ICU
|
length of ICU stay in days
|
up to 28 days after admission to ICU
|
|
prognosis
Time Frame: up to 28 days after admission to ICU
|
survival or death when transfer out of the ICU
|
up to 28 days after admission to ICU
|
|
acute physiology and chronic health evaluation II score
Time Frame: up to 3 days after admission to ICU
|
score range from 0-71, higher scores indicate a worse outcome
|
up to 3 days after admission to ICU
|
|
Sequential Organ Failure Assessment
Time Frame: up to 3 days after admission to ICU
|
score range from 0-15, higher scores indicate a worse outcome
|
up to 3 days after admission to ICU
|
|
Abdominal Gastrointestinal Index score
Time Frame: up to 3 days after admission to ICU
|
score range from 0-4, higher scores indicate a worse outcome
|
up to 3 days after admission to ICU
|
|
Abdominal Gastrointestinal Index Ultrasonography Score
Time Frame: up to 3 days after admission to ICU
|
score range from 0-10, higher scores indicate a worse outcome
|
up to 3 days after admission to ICU
|
|
Gastrointestinal Ultrasound Scoring score
Time Frame: up to 3 days after admission to ICU
|
score range from 0-10, higher scores indicate a worse outcome
|
up to 3 days after admission to ICU
|
|
semi-quantitative ultrasound score of gastric content
Time Frame: up to 3 days after admission to ICU
|
score range from 0-2, higher scores indicate a worse outcome
|
up to 3 days after admission to ICU
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
November 1, 2024
Primary Completion (Estimated)
August 1, 2025
Study Completion (Estimated)
December 31, 2025
Study Registration Dates
First Submitted
September 19, 2024
First Submitted That Met QC Criteria
October 8, 2024
First Posted (Actual)
October 10, 2024
Study Record Updates
Last Update Posted (Actual)
October 10, 2024
Last Update Submitted That Met QC Criteria
October 8, 2024
Last Verified
September 1, 2024
More Information
Terms related to this study
Other Study ID Numbers
- ZWQ21886-2024-2
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sepsis
-
University of California, San FranciscoNational Cancer Institute (NCI)RecruitingSepsis | Sepsis, Severe | Sepsis and Septic Shock | Sepsis at Intensive Care Unit | Sepsis, Septic Shock | Sepsis, Severe Sepsis and Septic Shock | Sepsis With Multiple Organ Dysfunction (MOD) | Sepsis With Acute Organ DysfunctionUnited States
-
Assiut UniversityNot yet recruitingSepsis Induced Myocardial Dysfunction | Sepsis Induced CardiomyopathyEgypt
-
University of Kansas Medical CenterUniversity of KansasRecruitingSepsis | Septic Shock | Sepsis Syndrome | Sepsis, Severe | Sepsis Bacterial | Sepsis BacteremiaUnited States
-
Jip GroenInBiomeRecruitingMicrobial Colonization | Neonatal Infection | Neonatal Sepsis, Early-Onset | Microbial Disease | Clinical Sepsis | Culture Negative Neonatal Sepsis | Neonatal Sepsis, Late-Onset | Culture Positive Neonatal SepsisNetherlands
-
Karolinska InstitutetÖrebro University, SwedenCompletedSepsis | Sepsis Syndrome | Sepsis, SevereSweden
-
The University of QueenslandRoyal Brisbane and Women's HospitalUnknown
-
Indonesia UniversityCompletedSevere Sepsis With Septic Shock | Severe Sepsis Without Septic ShockIndonesia
-
Ohio State UniversityCompletedSepsis, Severe Sepsis and Septic ShockUnited States
-
Beckman Coulter, Inc.Biomedical Advanced Research and Development AuthorityEnrolling by invitationSevere Sepsis | Severe Sepsis Without Septic ShockUnited States
-
University of LeicesterUniversity Hospitals, Leicester; The Royal College of AnaesthetistsCompletedSepsis | Septic Shock | Severe Sepsis | Sepsis SyndromeUnited Kingdom